C12Q 2523/101
Crosslinking agents
Official title: Crosslinking agents, e.g. psoralen
C12Q2523/101 (Crosslinking agents) appears on 12 US grants and 23 published applications in this corpus.
Search patents in C12Q- Granted patents
- 12
- Published applications
- 23
- Assignees
- 23
- Inventors
- 58
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 4 |
| 2019 | 0 | 5 |
| 2020 | 1 | 2 |
| 2021 | 1 | 3 |
| 2022 | 2 | 3 |
| 2023 | 3 | 3 |
| 2024 | 2 | 1 |
| 2025 | 1 | 0 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for genome assembly and haplotype phasing1 Sep 2026US 12,725,678 B2The Regents of the University of California
- Chromosome conformation markers of autism spectrum disorder28 Jul 2026US 12,692,543 B2Oxford Biodynamics PLC
- Swellable and structurally homogenous hydrogels and methods of use thereof25 Mar 2025US 12,258,454 B2Massachusetts Institute of Technology
- DNA-tagged methanol responsive polymer for single-stranded nucleic acid production24 Dec 2024US 12,173,351 B2Dana-Farber Cancer Institute, Inc.
- Swellable and structurally homogenous hydrogels and methods of use thereof16 Jan 2024US 11,873,374 B2Massachusetts Institute of Technology
- Application of epigenetic chromsomal interactions in cancer diagnostics27 Aug 2026US 2026/0250783 A1Oxford Biodynamics PLC
- Swellable and Structurally Homogenous Hydrogels and Methods of Use Thereof30 May 2024US 2024/0174818 A1Massachusetts Institute of Technology
- Application of epigenetic chromosomal interactions in cancer diagnostics16 Mar 2023US 2023/0082230 A1Oxford Biodynamics PLC
- Method for determination of 3d genome architecture with base pair resolution and further uses thereof2 Feb 2023US 2023/0032136 A1Baylor College of Medicine
- Method for performing multiple analyses on same nucleic acid sample2 Feb 2023US 2023/0032847 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents